Nasdaq GlobeNewswire

Orion Biotechnology Canada Acquires K2Biomedical

Del

OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the acquisition of K2Biomedical, a specialty pharmaceutical research company based in Cracow, Poland.  The acquisition will add drug development capabilities to Orion Biotechnology in Europe.

Founded in 2015, K2Biomedical was initially focused on the prevention of Sexually Transmitted Infections (STIs), including HIV.  With this acquisition K2Biomedical becomes Orion Biotechnology Poland SP. Z O.O.   The new entity will continue to be headquartered in the Jagiellonian Centre of Innovation in Cracow (Malopolska), Poland, focused on developing new technologies and product candidates for the global market.

"This transaction marks an important milestone for Orion Biotechnology and our stakeholders," said Mark Groper, CEO, Orion Biotechnology Canada.   "The team at K2Biomedical bring critical capabilities that will help us accelerate development of our new technologies."

Anatole Klepasky, COO, Orion Biotechnology added, "We are thrilled to add such a capable team to our organization.  They will further enhance our capacity to advance our pipeline of drug candidates in the field of oncology, neuroinflammatory disorders, as well as HIV prevention."

Adam Koprowski, General Director of Orion Biotechnology Poland SP. Z O.O added, "Access to the expertise and resources of Orion Biotechnology Canada will improve our company's capabilities to conduct upcoming R&D projects."

About Orion Biotechnology Canada, Ltd.
Orion Biotechnology Canada Ltd, is a privately held pharmaceutical company which is developing a range of novel medicines aimed at successful treatment and prevention of the most serious illnesses and life-threatening diseases. Since 2011, Orion has been developing a robust pipeline of potential products based on innovations from different parts of the world. Our close ties to diverse institutions and experts around the globe continue to stimulate the rapid discovery of promising new treatments. With operations in North America, Europe and Asia, Orion brings together innovative technologies from some of the world's leading research institutions such as the Mintaka Research Foundation and the Center for Public Health Research at Nanjing University. Learn more at www.orionbiotechnology.com.

Forward-Looking Statements
This press release contains forward-looking information, which reflects Orion's current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Orion's control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. These forward-looking statements are made as of the date of this press release and, except as expressly required by applicable law, Orion assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact: Ross MacLeod
Orion Biotechnology 
Canada Ltd
Phone: +1.343.291.1032
info@orionbiotechnology.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orion Biotechnology Canada Ltd via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Nasdaq Launches ESG futures in the Nordics15.10.2018 10:00Pressemelding

STOCKHOLM, Sweden, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the launch of futures based on the recently launched OMXS30 ESG Responsible index (OMXS30ESG). The product is the first exchange listed and ESG compliant index future in the world. “In recent years we have seen institutions increase efforts to integrate sustainability into their investment strategies, with the Nordic region being in the forefront of this trend,” says Alessandro Romani, Head of European Equity Derivatives at Nasdaq. “Those looking to invest in a more sustainable way need more investment products based on established and liquid indexes. Our existing OMXS30 index future contract is among the most traded in Europe and we expect to see the same interest for the ESG version.” The OMXS30ESG Index was developed in cooperation with a number of leading Nordic asset managers, including Swedbank Robur. “At Swedbank, innovation and constant development are an important part of the business, a

Telix and ANMI Expand PSMA Imaging Partnership15.10.2018 00:00Pressemelding

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), today announced that it has expanded its partnership with Advanced Nuclear Medicine Ingredients SA (“ANMI”) for the 68Ga-HBED-CC-PSMA-11 (68Ga-PSMA) cold kit. The 68Ga-PSMA kit is developed by ANMI and commercialized by Telix for the US market where it is marketed as illumetTM . In response to considerable clinical interest in the illumetTM product, Telix has commenced scale-up manufacturing in the United States, following the recent filing of a drug master file (DMF) and the launch of several major clinical trials using the product, including the 750 patient VISION phase III trial (Endocyte, Inc.) and a 500-patient phase II study at Memorial Sloan Kettering C

Brookfield Asset Management 2018 Third Quarter Results Conference Call And Webcast12.10.2018 15:33Pressemelding

Date: Thursday, November 8, 2018 Time: 11:00 a.m. (Eastern Time) BROOKFIELD, NEWS, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE:BAM)(TSX:BAM.A)(EURONEXT AMSTERDAM:BAMA): Third Quarter Conference Call You are invited to participate in Brookfield Asset Management’s 2018 Third Quarter Conference Call & Webcast on Thursday, November 8, 2018 at 11:00 a.m. (Eastern Time) to discuss with members of senior management our results and current business initiatives. These results will be released on November 8th before 7:00 a.m. (Eastern Time) and will be available following the release on our website at www.brookfield.com “News – Press Releases.” The Conference Call will also be Webcast live on our website, where it will be archived for future reference. To participate in the Conference Call, please dial (877) 255-3077 toll free in North America, or for overseas calls please dial (647) 252-4453 at approximately 10:50 a.m. The Conference Call will also be Webcast live at htt

Wasabi to Open its First European Data Center in Amsterdam11.10.2018 18:17Pressemelding

Provides Hot Cloud Storage Service for European Markets While Expanding Global Presence Boston, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Wasabi, the hot cloud storage company, today announces plans to open its first European data center in Amsterdam, NL this coming December. With the addition of its latest data center, Wasabi will make its international debut by offering EU markets the lowest cost, highest performance cloud storage service available, now with very low latency for European customers. Wasabi’s hot cloud storage service enables companies to store their data at one-fifth the cost and 6x the speed of Amazon S3 with no additional egress fees. Wasabi customers will have more connectivity options, additional data center redundancy, automatic data replication and failover services, and faster speeds with close proximity to their own data centers. With its newest data center opening, Wasabi enables high-speed exchange between Wasabi storage and customer compute resources with multiple

SIMEX reduces trading commissions11.10.2018 16:50Pressemelding

American Retail Group Inc. (aka Simex Inc.) the public corporation organized in the State of Nevada, USA LAS VEGAS, Oct. 11, 2018 (GLOBE NEWSWIRE) -- (OTC: ARGB) -- SIMEX Inc. announces reducing trading commissions. Current trading commissions are set to 0.1% for both sides maker/taker which is 50% lower than before. Vassili Oxenuk, the President of SIMEX, said: "By reducing trading commissions we become more attractive to traders on the digital assets market." Trading commissions can be even reduced to 0%. SMX Token allows you to reduce the commissions when trading on the SIMEX Exchange. Commissions rate depending on the balance of the user's account*: 1 000 SMX: 0.075% Maker / 0.075% Taker. 5 000 SMX: 0.05% Maker / 0.05% Taker. 10 000 SMX: 0% Maker / 0% Taker. Contact information: Email: info@simex.global Headquarters: 2300 West Sahara, Office 400, Las Vegas, 89102

Fortuna reports heavy seasonal rains caused an overflow in a contingency pond of the dry stack tailings facility at the San Jose Mine, Mexico11.10.2018 16:46Pressemelding

VANCOUVER, B.C., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that in the early morning of October 8th, abnormally high rainfall caused a contingency pond to overflow at the dry stack tailings facility at the San Jose mine located in Oaxaca, Mexico. The contingency pond collects water from a ditch system at the dry stack facility designed to capture and manage rain water. The Company wants to emphasize that no industrial process water was discharged in this incident and that the San Jose operation uses a cyanide-free process to produce concentrate. The dry stack contingency pond’s holding capacity is 7,000 cubic meters and it is equipped with a 600 cubic meter per hour pumping capacity that was surpassed by the volume of rain fall. The overflow occurred for about two hours at approximately 4:00 am and resulted in the spill of approximately 1,500 cubic meters of water carrying sediment and minor amounts of fine tailings from the facility’s d

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom